Quick Answer
DEXCOM INC reported Common Stock Shares Outstanding of 384.80 million shares for the year ending 2025.
- DEXCOM INC showed a decrease of -1.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from DEXCOM INC's annual report (Form 10-K), filed with the SEC on February 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), DEXCOM INC's Common Stock Shares Outstanding has grown by 519.9%.
- Historical annual values: Fiscal year 2025: 384.80 million shares | Fiscal year 2024: 390.70 million shares | Fiscal year 2023: 385.40 million shares | Fiscal year 2022: 386.30 million shares | Fiscal year 2021: 388.00 million shares | Fiscal year 2020: 96.10 million shares | Fiscal year 2019: 91.60 million shares | Fiscal year 2018: 90.00 million shares | Fiscal year 2017: 87.00 million shares | Fiscal year 2016: 84.60 million shares | Fiscal year 2015: 81.70 million shares | Fiscal year 2014: 77.30 million shares | Fiscal year 2013: 72.50 million shares | Fiscal year 2012: 69.50 million shares | Fiscal year 2011: 67.50 million shares | Fiscal year 2010: 62.08 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: